Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. Subscribe to
Alpha Pro Tech, Ltd. (AMEX:APT) was one of the top gainers in today’s trading session and rallied 8.85% or $0.53 to close at $6.52 on an unusual massive volume of 1.56 million shares. The stock touched an intraday high and low of $6.778 and $6.20 respectively. So far in the last six months the stock has rallied over 297%. Alpha Pro Tech, Ltd. (Alpha Pro Tech) is in the business of protecting people, products and environments. The Company accomplishes this by developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets.
Protalix BioTherapeutics Inc. (AMEX:PLX) was one of the top gainers in today’s trading session as it rallied over 10% and closed at $10.43 on huge volume of 1.49 million shares after Reuters reported that, according to TheMarker financial newspaper, Pfizer is considering a cooperation deal with Protalix BioTherapeutics Inc. and may even try to buy the Company. The stock price made a new 52 week high of $10.47.
YM BioSciences Inc. (USA) (AMEX:YMI) shares jumped over 10% or $0.13 to end the day at $1.42 on 1.36 million shares after today it announced that an oral presentation at the American Society for Therapeutic Radiology and Oncology (ASTRO) 2009 Annual Meeting reported positive 48-month survival data for its EGFR-targeting antibody, nimotuzumab. The BEST trial was a randomized four-arm study treating patients with inoperable, locoregionally-advanced, stage III/IVa head and neck cancer with radiation alone, chemoradiation alone, or radiation or chemoradiation in combination with nimotuzumab. These data were a follow-up to 30-month survival data presented at ASCO 2009 and demonstrate that the benefit of adding nimotuzumab to radiation and chemoradiation is durable and persists for several years.